Advanced Optics Electronics Inc. OKs Beta Testing for 'Color-Chek'; Mexico Gives Biomoda Inc. 'Patent Pending' Green Light.Business Editors/Health/Medical Writers/High-Tech Writers ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Sept. 3, 2003 Multiple location Beta testing (programming) beta testing - Testing a pre-release (potentially unreliable) version of a piece of software by making it available to selected users. This term derives from early 1960s terminology for product cycle checkpoints, first used at IBM but later standard throughout the is the protocol selected for "COLOR-CHEK," the color speech processor development underway at Advanced Optics Electronics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ). The next phase of prototype rating slated to be completed before month's end will be undertaken in such a manner as to simultaneously field test in a variety of environments. Testing to date, conducted to comply with nearly absolute parameters, although not yet certified, has demonstrated readings far greater than anticipated. Mexico's Federal Patent Agency granted "Patent Pending" status to Biomoda Inc.'s proprietary systems now enabling Biomoda Inc. to target this adjacent 80 million plus population. The addition of Mexico's vast market, long sought by Biomoda now positions Biomoda with 18 countries in which to target its launch. Biomoda Inc.'s market sponsorship has been completed by its newly authorized au·thor·ize tr.v. au·thor·ized, au·thor·iz·ing, au·thor·iz·es 1. To grant authority or power to. 2. To give permission for; sanction: initial market maker allowing Biomoda to move toward publicly traded status upon completion of the NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). processing. A symbol will be assigned for quotation and trading purposes. ADOT's existing balance sheet valuation, cost less depreciation resulted in the current reduced carrying value Carrying Value Also know as "book value," it is a company's total assets minus intangible assets and liabilities, such as debt. Notes: This is different than market value, as it can be higher or lower depending on the circumstances. . This will be positively affected by Biomoda's scheduled $6 per share market price to be reflected in the Dec. 31, 2003 balance sheet audit likely producing a marked increase in ADOT's net worth. Biomoda Inc. is scheduling the first addition to its professional staff with the addition of an individual with industry background to direct the commercial market entry of its patented cancer diagnostics programs. This effort, geared to achieve key intermediate benchmarks required for broad-based commercialization initially will be through clinical trials. Developments with global regional partners for targeted areas of testing and product development is intended to ensure both marketplace education and penetration. Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays A thin display screen for computer and TV usage. The first flat panels appeared on laptop computers in the mid-1980s, and the LCD technology became the standard. Stand-alone LCD screens became available for desktop computers in the mid-1990s and exceeded sales of CRTs for the first time utilizing its patented and patent-pending technology. In addition to the core business of ADOT, the company has made a strategic technology oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds directly and indirectly 30% of Biomoda Inc. This news release contains forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its quarterly reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion